Pendal Group LTD Bristol Myers Squibb CO Transaction History

Pendal Group LTD

$12.2 Billion
Q4 2022

A detailed history of Pendal Group LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pendal Group LTD holds 8,767 shares of BMY stock, worth $510,502. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,767

Previous 12,988 32.5%

Holding current value

$510,502

Previous $924,000 31.82%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	SELL	$68.48 - $81.09 $289,054 - $342,280	-4,221 Reduced 32.5%	8,767 $0
Q3 2022 Oct 18, 2022	BUY	$0.13 - $76.84 $44 - $26,432	344 Added 2.72%	12,988 $924,000
Q2 2022 Jul 25, 2022	SELL	$72.62 - $79.98 $1.79 Million - $1.97 Million	-24,628 Reduced 66.08%	12,644 $974,000
Q4 2021 Jan 18, 2022	BUY	$53.63 - $62.52 $2 Million - $2.33 Million	37,272 New	37,272 $2.32 Million
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $936,601 - $1.1 Million	-15,829 Closed	0 $0
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $739,453 - $805,264	-11,944 Reduced 43.01%	15,829 $1.06 Million
Q1 2021 May 24, 2021	BUY	$59.34 - $66.74 $1.65 Million - $1.85 Million	27,773 New	27,773 $1.75 Million
Q1 2021 May 03, 2021	SELL	$59.34 - $66.74 $2.03 Million - $2.28 Million	-34,179 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$57.74 - $65.43 $1.47 Million - $1.67 Million	-25,512 Reduced 42.74%	34,179 $2.12 Million
Q3 2020 Nov 02, 2020	BUY	$57.43 - $63.64 $1.89 Million - $2.09 Million	32,877 Added 122.61%	59,691 $3.6 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $598,086 - $699,221	10,910 Added 68.6%	26,814 $1.58 Million
Q1 2020 May 04, 2020	SELL	$46.4 - $67.43 $2.19 Million - $3.18 Million	-47,174 Reduced 74.79%	15,904 $886,000
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $2.94 Million - $3.83 Million	59,692 Added 1762.91%	63,078 $4.05 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $9.56 Million - $11.3 Million	-223,613 Reduced 98.51%	3,386 $171,000
Q2 2019 Aug 01, 2019	SELL	$44.62 - $49.34 $6.34 Million - $7.01 Million	-142,040 Reduced 38.49%	226,999 $0
Q1 2019 May 01, 2019	BUY	$45.12 - $53.8 $1.17 Million - $1.39 Million	25,920 Added 7.55%	369,039 $0
Q4 2018 Jan 30, 2019	BUY	$48.76 - $63.23 $8.1 Million - $10.5 Million	166,187 Added 93.93%	343,119 $17.8 Million
Q3 2018 Nov 05, 2018	SELL	$55.19 - $62.25 $3.36 Million - $3.79 Million	-60,916 Reduced 25.61%	176,932 $0
Q2 2018 Jul 18, 2018	BUY	$50.53 - $62.98 $2.21 Million - $2.75 Million	43,663 Added 22.49%	237,848 $0
Q1 2018 May 08, 2018	SELL	$59.92 - $68.98 $1.18 Million - $1.36 Million	-19,720 Reduced 9.22%	194,185 $0
Q4 2017 Feb 06, 2018	BUY	$59.94 - $65.35 $2.97 Million - $3.24 Million	49,551 Added 30.15%	213,905 $0
Q3 2017 Nov 01, 2017	BUY	$55.23 - $63.74 $3.09 Million - $3.57 Million	56,032 Added 51.73%	164,354 $0
Q2 2017 Aug 11, 2017	BUY	N/A	108,322	108,322 $0

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Account